Search clinical trials for: ramelteon

Total 76 results

Shriners Hospitals for Children
Children's Hospital Medical Center, Cincinnati

Completed

Differential Effects of Zolpidem Versus Ramelteon in Burned Children (Sleep3)

Burns | Sleep

United States
Associação Fundo de Incentivo à Pesquisa

Unknown

Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19

Covid19 | Lung Injury
Northwestern University
Takeda

Terminated

Ramelteon for Insomnia Comorbid With Asthma

Insomnia | Asthma

United States
Massachusetts General Hospital
Takeda

Completed

Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

United States
US Department of Veterans Affairs
Takeda; Stanford University

Completed

Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia

Insomnia | Sleep Disorders | Spinal Cord Injury | Tetraplegia

United States
Translational Research Center for Medical Innovation...
Yoyogi Sleep Disorder Clinic, Foundation of Sleep and Health Science

Completed

The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia (BRED)

Chronic Insomnia

Japan
Swedish Medical Center
Takeda

Terminated

A Study of a Melatonin Receptor Agonist to Prevent Migraine

Migraine | Migraine Without Aura | Migraine With Aura

United States
Takeda

Completed

Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia

Sleep Initiation and Maintenance Disorders
Kessler Foundation

Unknown

Effect of Rozerem on Sleep Among People With Traumatic Brain Injury

Brain Injury | Insomnia

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Effect of Ramelteon on Smoking Abstinence (RAP)

Tobacco Use Disorder

United States
Takeda

Terminated

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Acute Depressive Episode

United States, Argentina, Chile, Colombia, Mexico
Duke University

Completed

Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance

Insomnia
University of Texas Southwestern Medical Center

Withdrawn

Ramelteon and Citicoline for Delirium

Delirium

United States
Takeda

Completed

Safety of Ramelteon in Elderly Subjects

Insomnia

United States
Utrecht Institute for Pharmaceutical Sciences
Takeda

Completed

Effects of Ramelteon on Driving Ability

Insomnia

Netherlands
All India Institute of Medical Sciences, Bhubaneswar

Completed

Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia

Schizophrenia

India
Takeda

Completed

Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia

Sleep Initiation and Maintenance Disorders
Takeda

Completed

Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia

Balance

United Kingdom
University of Texas Southwestern Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon (TAKEDA)

Insomnia | Major Depressive Disorder

United States
Novartis Pharmaceuticals

Terminated

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. (INFORMS)

Primary Progressive Multiple Sclerosis

United States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
Johns Hopkins University
National Institute on Aging (NIA)

Completed

Ramelteon in the Prevention of Post-operative Delirium (RECOVER)

Delirium | Delayed Emergence From Anesthesia | Delirium, Dementia, Amnestic, Cognitive Disorders | Cognitive Disorders

United States
University of Washington
University of Colorado, Denver; Gilead Sciences; Kenya Medical Research Institute

Completed

The Women TAF-FTC Benchmark Study

HIV Infections

Kenya
Takeda

Completed

Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse

Drug Abuse

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA); Food and Drug Administration (FDA)

Completed

The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep

Marijuana Dependence

United States
Takeda

Completed

Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia

Chronic Insomnia

United States
Milton S. Hershey Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Insomnia | Panic Disorder

United States

Search clinical trials for: ramelteon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations